BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 8889266)

  • 21. Comparison of peripheral and central effects of single and repeated oral dose administrations of bilastine, a new H1 antihistamine: a dose-range study in healthy volunteers with hydroxyzine and placebo as control treatments.
    García-Gea C; Martínez-Colomer J; Antonijoan RM; Valiente R; Barbanoj MJ
    J Clin Psychopharmacol; 2008 Dec; 28(6):675-85. PubMed ID: 19011437
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of bepotastine, cetirizine, fexofenadine, and olopatadine on histamine-induced wheal-and flare-response, sedation, and psychomotor performance.
    Takahashi H; Ishida-Yamamoto A; Iizuka H
    Clin Exp Dermatol; 2004 Sep; 29(5):526-32. PubMed ID: 15347340
    [TBL] [Abstract][Full Text] [Related]  

  • 23. H1-antihistamines and the central nervous system.
    Welch MJ; Meltzer EO; Simons FE
    Clin Allergy Immunol; 2002; 17():337-88. PubMed ID: 12113223
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The effects of single and repeated administration of ebastine on cognition and psychomotor performance in comparison to triprolidine and placebo in healthy volunteers.
    Hindmarch ; Shamsi Z
    Curr Med Res Opin; 2001; 17(4):273-81. PubMed ID: 11922401
    [TBL] [Abstract][Full Text] [Related]  

  • 25. First and second generation H₁ histamine receptor antagonists produce different sleep-inducing profiles in rats.
    Unno K; Ozaki T; Mohammad S; Tsuno S; Ikeda-Sagara M; Honda K; Ikeda M
    Eur J Pharmacol; 2012 May; 683(1-3):179-85. PubMed ID: 22449385
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Recent advances in H1-receptor antagonist treatment.
    Simons FE
    J Allergy Clin Immunol; 1990 Dec; 86(6 Pt 2):995-9. PubMed ID: 1979802
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Central effects of the H1-antihistamine, cetirizine.
    Nicholson AN; Turner C
    Aviat Space Environ Med; 1998 Feb; 69(2):166-71. PubMed ID: 9491258
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Comparative activity of antihistamines on area under dose-response curve from histamine-induced wheal and flare responses in human skin].
    Wang RQ; Zhang HY
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2004 Dec; 26(6):634-8. PubMed ID: 15663222
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Intravenous administration of diphenhydramine reduces histamine-induced vasodilator effects in the retina and choroid.
    Weigert G; Zawinka C; Resch H; Schmetterer L; Garhöfer G
    Invest Ophthalmol Vis Sci; 2006 Mar; 47(3):1096-100. PubMed ID: 16505046
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Sedation and performance issues in the treatment of allergic conditions.
    Adelsberg BR
    Arch Intern Med; 1997 Mar; 157(5):494-500. PubMed ID: 9066452
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Nonsedating H1 antihistamines in chronic urticaria.
    Monroe EW
    Ann Allergy; 1993 Dec; 71(6):585-91. PubMed ID: 7903515
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Modification of antihistaminic activity of cetirizine by nimesulide.
    Rewari S; Gupta U
    J Assoc Physicians India; 1999 Apr; 47(4):389-92. PubMed ID: 10778521
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Central nervous system side-effects of antihistamines in schoolchildren.
    Feldman W; Shanon A; Leiken L; Ham-pong A; Peterson R
    Rhinol Suppl; 1992 Sep; 13():13-9. PubMed ID: 1358139
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The effects of single-dose fexofenadine, diphenhydramine, and placebo on cognitive performance in flight personnel.
    Bower EA; Moore JL; Moss M; Selby KA; Austin M; Meeves S
    Aviat Space Environ Med; 2003 Feb; 74(2):145-52. PubMed ID: 12602446
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparison of the effects of desloratadine and levocetirizine on histamine-induced wheal, flare and itch in human skin.
    Denham KJ; Boutsiouki P; Clough GF; Church MK
    Inflamm Res; 2003 Oct; 52(10):424-7. PubMed ID: 14520518
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Efficacy and safety of mizolastine 10 mg in a placebo-controlled comparison with loratadine in chronic idiopathic urticaria: results of the MILOR Study.
    Dubertret L; Murrieta Aguttes M; Tonet J
    J Eur Acad Dermatol Venereol; 1999 Jan; 12(1):16-24. PubMed ID: 10188144
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The acute and sub-chronic effects of levocetirizine, cetirizine, loratadine, promethazine and placebo on cognitive function, psychomotor performance, and weal and flare.
    Hindmarch I; Johnson S; Meadows R; Kirkpatrick T; Shamsi Z
    Curr Med Res Opin; 2001; 17(4):241-55. PubMed ID: 11922397
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of second-generation histamine H1 receptor antagonists on the sleep-wakefulness cycle in rats.
    Shigemoto Y; Shinomiya K; Mio M; Azuma N; Kamei C
    Eur J Pharmacol; 2004 Jun; 494(2-3):161-5. PubMed ID: 15212970
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pharmacodynamics of the new H1-antagonist 3-amino-9,13b-dihydro-1H-dibenz[c,f]imidazo[1,5-a]azepine hydrochloride in volunteers.
    Adamus WS; Oldigs-Kerber J; Lohmann H
    Arzneimittelforschung; 1987 May; 37(5):569-72. PubMed ID: 2887173
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of nonsedating histamine H1-antagonists on EEG activity and behavior in the cat.
    Marzanatti M; Monopoli A; Trampus M; Ongini E
    Pharmacol Biochem Behav; 1989 Apr; 32(4):861-6. PubMed ID: 2572005
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.